• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Tumbles Over 100 Points; US Producer Prices Decline In May

    6/13/24 9:45:42 AM ET
    $BRTX
    $BURU
    $CARA
    $EJH
    Managed Health Care
    Health Care
    Industrial Machinery/Components
    Miscellaneous
    Get the next $BRTX alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones index falling by more than 100 points on Thursday.

    Following the market opening Thursday, the Dow traded down 0.36% to 38,574.00 while the NASDAQ rose 0.55% to 17,705.52. The S&P 500 also rose, gaining, 0.19% to 5,431.23.

    Check This Out: Alphabet, Dropbox And 2 Other Stocks Insiders Are Selling

    Leading and Lagging Sectors

    Information technology shares jumped by 1.4% on Thursday.

    In trading on Thursday, communication services shares fell by 0.9%.

    Top Headline

    U.S. producer prices fell by 0.2% month-over-month in May versus market estimates of a 0.1% gain and following a 0.5% increase in April.

    Equities Trading UP
                           

    • BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares shot up 60% to $2.1399 after the company announced that it engaged in advanced discussions for a ThermoStem license with a regenerative medicine firm.
    • Shares of E-Home Household Service Holdings Limited (NASDAQ:EJH) got a boost, surging 42% to $0.8500.
    • Sharps Technology, Inc. (NASDAQ:STSS) shares were also up, gaining 40% to $0.4181 after the company announced that it signed a $30 million purchase order from Nephron Pharmaceuticals for prefillable copolymer syringes.

    Equities Trading DOWN

    • Assure Holdings Corp. (NASDAQ:IONM) shares dropped 45% to $0.2862.
    • Shares of Nuburu, Inc. (NASDAQ:BURU) were down 36% to $0.0933 after the company announced that it will be implementing a 1-for-40 reverse stock split.
    • Cara Therapeutics, Inc. (NASDAQ:CARA) was down, falling 32% to $0.4631 after the company announced the outcome from the dose-finding Part A of the KOURAGE-1 study evaluating the efficacy and safety of oral difelikefalin for moderate-to-severe pruritus in adult patients with notalgia paresthetica. Also, Needham, Canaccord Genuity and HC Wainwright downgraded their respective ratings on the stock.

    Also Check This Out: Wall Street’s Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields

    Commodities

    In commodity news, oil traded down 0.4% to $78.18 while gold traded down 0.7% at $2,338.80.

    Silver traded down 2.7% to $29.445 on Thursday, while copper fell 0.5% to $4.5425.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 0.7%, Germany's DAX dipped 1% and France's CAC 40 tumbled 1.1%. Spain's IBEX 35 Index fell 0.6%, while London's FTSE 100 slipped 0.3%.

    Industrial production in the Eurozone fell by 0.1% month-over-month in April following a revised 0.5% gain in the prior month. The annual inflation rate in Spain accelerated for the third month to 3.6% in May.

    Germany’s wholesale prices declined by 0.7% year-over-year in May compared to a 1.8% fall in the prior month.

    Asia Pacific Markets

    Asian markets closed mixed on Thursday, with Japan's Nikkei falling 0.40%, Hong Kong's Hang Seng Index gaining 0.97%, China's Shanghai Composite Index falling 0.28% and India's S&P BSE Sensex gaining 0.27%.

    The Hong Kong Monetary Authority kept its base rate unchanged at 5.75% during its latest meeting.

    Economics

    • U.S. initial jobless claims rose by 13,000 to 242,000 in the week ending June 8, compared to market estimates of 225,000.
    • U.S. producer prices fell by 0.2% month-over-month in May versus market estimates of a 0.1% gain and following a 0.5% increase in April.

    Now Read This: Top 3 Tech And Telecom Stocks You’ll Regret Missing In Q2

    Get the next $BRTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BRTX
    $BURU
    $CARA
    $EJH

    CompanyDatePrice TargetRatingAnalyst
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Hold
    Needham
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Neutral
    H.C. Wainwright
    Cara Therapeutics Inc.
    $CARA
    3/8/2023$13.00 → $6.00Neutral → Underperform
    BofA Securities
    Cara Therapeutics Inc.
    $CARA
    3/8/2022$17.00 → $20.00Neutral → Overweight
    JP Morgan
    BioRestorative Therapies Inc.
    $BRTX
    12/1/2021$37.00Buy
    Roth Capital
    Cara Therapeutics Inc.
    $CARA
    11/1/2021$33.00Buy
    Canaccord Genuity
    More analyst ratings

    $BRTX
    $BURU
    $CARA
    $EJH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BRTX
    $BURU
    $CARA
    $EJH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ruemler Timothy James increased direct ownership by 294% to 40,218 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:45:47 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Crescenzo Andrew R. bought $256,400 worth of Option (40,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:34 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Monroe Jason L. bought $512,800 worth of Option (80,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:36 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $BRTX
    $BURU
    $CARA
    $EJH
    SEC Filings

    View All

    SEC Form SCHEDULE 13D filed by Sharps Technology Inc.

    SCHEDULE 13D - Sharps Technology Inc. (0001737995) (Subject)

    2/13/26 4:15:01 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form 424B4 filed by BioRestorative Therapies Inc.

    424B4 - BioRestorative Therapies, Inc. (0001505497) (Filer)

    2/13/26 9:48:15 AM ET
    $BRTX
    Managed Health Care
    Health Care

    SEC Form EFFECT filed by Nuburu Inc.

    EFFECT - Nuburu, Inc. (0001814215) (Filer)

    2/13/26 12:15:22 AM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    $BRTX
    $BURU
    $CARA
    $EJH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 5 filed by Ricchebuono Matteo

    5 - Nuburu, Inc. (0001814215) (Issuer)

    2/13/26 6:47:10 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 3 filed by new insider Ricchebuono Matteo

    3 - Nuburu, Inc. (0001814215) (Issuer)

    2/13/26 6:42:12 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    Large owner Falconx Holdings Ltd sold $1,490,755 worth of shares (769,320 units at $1.94) and exercised 461,538 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    2/13/26 4:45:04 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $BRTX
    $BURU
    $CARA
    $EJH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cara Therapeutics downgraded by Stifel with a new price target

    Stifel downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $6.00 previously

    6/13/24 7:05:24 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cara Therapeutics downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $10.00 previously

    6/13/24 7:05:04 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cara Therapeutics downgraded by Needham

    Needham downgraded Cara Therapeutics from Buy to Hold

    6/13/24 7:04:33 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BRTX
    $BURU
    $CARA
    $EJH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioRestorative Announces Closing of $5.0 Million Public Offering

    MELVILLE, N.Y., Feb. 13, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a late stage clinical regenerative medicine innovator focused on stem cell-based therapies and products, today announced the closing of its previously announced public offering of 14,285,715 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 14,285,715 shares of common stock, at a combined public offering price of $0.35 per share (or pre-funded warrant in lieu thereof) and accompanying warrants. The warrants have an exercise price of $0.35 per share, are immediately exercisable and will expire five years from

    2/13/26 8:30:00 PM ET
    $BRTX
    Managed Health Care
    Health Care

    NUBURU Activates Q1 2026 Production Ramp for 40 High-Power Blue Laser Systems, Marking Scalable Industrial Execution Under Defense Platform Strategy

    ~$850,000 Production Activation Demonstrates Revenue Reactivation and Scalable Industrial Execution Under NUBURU's Defense Transformation Plan NUBURU, Inc. (NYSE:BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, and software-orchestrated defense systems, today announced the activation of its Q1 2026 structured production ramp through its wholly owned operating subsidiary Lyocon S.r.l., following a previously awarded contract valued at approximately $850,000. The order consists of 40 high-power 450nm blue laser systems for Dutch agritech automation company Trabotyx, including: 24 units – 100W systems 16 units – 200W

    2/13/26 7:45:00 AM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    NUBURU Prices ~$12M Public Offering to Accelerate Execution of Defense & Security Transformation Plan

    NUBURU, Inc. (NYSE:BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, and software-orchestrated defense systems, today announced the pricing of a $12 million public offering. The financing is intended to accelerate execution of the Company's Defense & Security Transformation Plan and strengthen the Company's capital position as it advances its integrated Defense & Security platform strategy. The public offering consisted of the issuance and sale of approximately $12 million of common stock and pre-funded warrants in lieu of shares at a subscription price of $0.11 per share and $0.1099 per pre-funded warrant, representing 58,

    2/12/26 10:19:00 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    $BRTX
    $BURU
    $CARA
    $EJH
    Leadership Updates

    Live Leadership Updates

    View All

    NUBURU Strengthens Balance Sheet, Advances Defense-Tech Acquisition Program and Revamps Blue-Laser Business

    Executing Transformation Plan spanning Maddox Defense drones, Tekne special-mission vehicles, and Orbit critical-infrastructure software to build a unified defense-tech platform with expanding NATO traction. Blue-laser technology' business acquisition on track. NUBURU, Inc. (NYSE:BURU) ("NUBURU" or the "Company") continued strengthening its balance sheet during the quarter through disciplined capital deployment, selective drawdowns under its Standby Equity Purchase Agreement when beneficial, and further reduction of legacy payables. Cash on hand remains robust as NUBURU strategically allocates capital to high-value defense and security growth initiatives under its Transformation Plan. "We

    11/6/25 7:30:00 AM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

    MELVILLE, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that Crystal Romano has joined its management team. In her role, Ms. Romano will be responsible for leading BioRestorative's global commercial operations and innovation. A seasoned executive with over 19 years of progressive leadership in the medical, aesthetics, and regenerative industries, Ms. Romano is recognized for her expertise in product development and innovation, commercialization, sales and account management, clinical and product training, a

    10/22/25 9:35:00 AM ET
    $BRTX
    Managed Health Care
    Health Care

    BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team

    MELVILLE, N.Y., June 10, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, announced today its hiring of Industry leader, Sandy Lipkins, to focus on technology commercialization and business development, effective June 9, 2025. In his role, Mr. Lipkins will be responsible for sourcing, structuring, negotiating and executing strategic alliances and licensing/co-development agreements for BioRestorative domestically and internationally, as well as providing new product and sales expertise to the Company. Mr. Lipkins has an accom

    6/10/25 8:00:00 AM ET
    $BRTX
    Managed Health Care
    Health Care

    $BRTX
    $BURU
    $CARA
    $EJH
    Financials

    Live finance-specific insights

    View All

    BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025

    MELVILLE, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it will release its third quarter 2025 financial results after market close on Wednesday, November 12, 2025. Following the announcement, BioRestorative management will host a conference call to review the financial results and provide a business update. Third Quarter 2025 Results Conference Call Details: Date: Wednesday, November 12, 2025Time: 4:30 p.m. ETDomestic: 1-888-506-0062International: 1-973-528-0011Access Code: 464585 The call will also b

    11/5/25 4:30:00 PM ET
    $BRTX
    Managed Health Care
    Health Care

    NUBURU Restores NYSE Compliance and Strengthens Defense Transformation With Its Acquisition Plan Underway

    Technical communication issue resolved earlier this week; dual-CEO team driving rapid expansion, regulatory excellence, and new stages of growth across defense and industrial innovation sectors NUBURU, Inc. (NYSE:BURU) ("NUBURU" or the "Company"), a pioneer in next-generation blue-laser defense and advanced manufacturing technologies, today reaffirmed that it remains in full compliance with NYSE American regulatory disclosure requirements. This statement follows the resolution of a technical communication timing issue earlier this week, which was related to the coordination of press release dissemination with the Exchange. The Company received a non-compliance warning earlier this week

    10/16/25 7:00:00 AM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain

    NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced its first acquisition of Solana ("SOL") tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Funded from the Company's recent PIPE equity raise, Sharps Technology now holds over 2 million SOL, creating a SOL treasury currently valued north of $400M. Sharps Technology intends to provide regular updates on its SOL holdings and performan

    9/2/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $BRTX
    $BURU
    $CARA
    $EJH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nuburu Inc.

    SC 13D/A - Nuburu, Inc. (0001814215) (Subject)

    11/25/24 8:59:19 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    11/13/24 4:50:17 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by Cara Therapeutics Inc.

    SC 13D - Cara Therapeutics, Inc. (0001346830) (Subject)

    10/30/24 4:21:50 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care